Title

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges

UMMS Affiliation

Lysosomal Disorders Treatment and Research Program; Department of Psychiatry; Department of Neurology

Publication Date

2020-05-11

Document Type

Article

Disciplines

Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Health Services Administration | Infectious Disease | Nervous System Diseases | Nutritional and Metabolic Diseases | Virus Diseases

Abstract

A group of investigators and physician experts in Gaucher disease along with patient advocacy organizations in the United States convened to propose management guidelines and to identify research questions during these challenging times. The overarching goal of this collaborative group is to delineate the emerging impact of the SARS-CoV-2 pandemic on patients with Gaucher disease and to develop optimal clinical practice guidelines for managing the infection.

Keywords

SARS-CoV-2, COVID-19, pandemic, Gaucher disease

DOI of Published Version

10.1016/j.ymgme.2020.05.002

Source

Mistry P, Balwani M, Barbouth D, Burrow TA, Ginns EI, Goker-Alpan O, Grabowski GA, Kartha RV, Kishnani PS, Lau H, Lee CU, Lopez G, Maegawa G, Packman S, Prada C, Rosenbloom B, Lal TR, Schiffmann R, Weinreb N, Sidransky E. Gaucher disease and SARS-CoV-2 infection: Emerging management challenges. Mol Genet Metab. 2020 Jul;130(3):164-169. doi: 10.1016/j.ymgme.2020.05.002. Epub 2020 May 11. PMID: 32471800; PMCID: PMC7211677. Link to article on publisher's site

Journal/Book/Conference Title

Molecular genetics and metabolism

Comments

Full author list omitted for brevity. For the full list of authors, see article.

Related Resources

Link to Article in PubMed

PubMed ID

32471800

Share

COinS